Harnessing AI to Advance Clinical Trials and Oncology Pharmacy
AI is transforming oncology by enhancing clinical trials, personalizing treatments, and improving pharmacy practices, promising faster, more precise cancer care.
Bisphenol A as a Promoter of Hormone-Sensitive Breast Cancer Through Inflammatory Pathways
BPA exposure accelerates ER+ breast cancer growth, impacting treatment efficacy and altering the pharmacist’s role in therapy administration.
Non-Invasive Saliva Tests Could Offer Early Clues for Diabetes and Obesity Risk
Researchers reveal that saliva tests for insulin levels offer a non-invasive method to predict type 2 diabetes and obesity risks…
Changing the Course of SCD: One Dose of Hydroxyurea at a Time
Mona El-Mouwfi explores how pharmacists enhance hydroxyurea therapy for sickle cell disease, improving patient outcomes and addressing treatment barriers effectively.
Building Bridges: Multidisciplinary Care and Patient Education Excellence for TD
Panelists discuss how pharmacists play a vital role in ensuring personalized care for tardive dyskinesia patients by fostering continuous, secure…
Pharmacist-Led Adherence Strategies for Patients Living With TD
Panelists discuss how pharmacists enhance treatment adherence in older adults with tardive dyskinesia by assessing cognitive function, involving caregivers, linking…
1049: If you can get your lab to do with this urine cultures you’ll use fewer antibiotics
Show notes at pharmacyjoe.com/episode1049. In this episode, I’ll discuss conditional reflex urine culturing for antibiotic stewardship. The post 1049: If…
IVIG Therapy: Mechanisms, Formulations, and Key Considerations for Safe and Effective Use
Intravenous immunoglobulin (IVIG) is a vital treatment for immunodeficiency and autoimmune disorders, with diverse mechanisms, brand-specific differences, and patient-centered considerations…
Video: Pharmacists Take Center Stage in Delivering Linvoseltamab, Advancing Myeloma Care
Sundar Jagannath, MBBS, highlights pharmacists’ expanding role in managing linvoseltamab’s immunologic profile, supporting adverse event response, and advancing multiple myeloma…
From Clinic to Hospital: Oncology Pharmacists Driving Seamless Site-of-Care Transitions
Eileen Peng, PharmD, discusses how her team has restructured pharmacy services to support outpatient administration of CAR T-cell and bispecific…